The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of IBD requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of IBD quality of life treatment includes multidimensional management such as personalized development, usually drug therapy, rehabilitation intervention, regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in conditions. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of quality of life associated with IBD. The platform serves a team of domestic and foreign experts in the field of infectious respiratory digestive endocrine in China.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.